Bioventix
BVXP · AIM · Health Care · mcap £88m · 1825.0p
Directors
purchase Bioventix PLC announced that its Chief Financial Officer, Bruce Hiscock, purchased 119 ordinary shares at an average price of 2,009 pence per share on October 27, 2025. Following this transaction, Hiscock's total benefic 27 Oct 2025
purchase On October 29, 2025, Ian Nicholson, Non-Executive Chairman of Bioventix PLC, purchased 500 ordinary shares at a price of 1,865 pence per share. The ordinary shares are of 5 pence each. Following this transaction, Nichols 30 Oct 2025
purchase Bioventix PLC announced that on 4 November 2025, Chief Executive Officer Peter Harrison and his wife, Abigail Harrison, each purchased 875 ordinary shares at 2,220 pence per share on the London Stock Exchange's AIM Marke 4 Nov 2025
purchase Bioventix plc announced that its Chief Financial Officer, Bruce Hiscock, purchased 150 ordinary shares at an average price of 2,071 pence per share on November 25, 2025. This transaction increases his beneficial interest 26 Nov 2025
other Bioventix PLC announced the appointment of Chris Yates as an independent Non-Executive Director, effective March 1, 2026, bringing over 20 years of public company experience, including a decade leading Abingdon Health pl 24 Feb 2026
purchase Bioventix plc announced that Chief Financial Officer Bruce Hiscock purchased 126 ordinary shares at 1,622 pence per share on April 2, 2026, for a total investment of £2,043.72. Following this transaction, Mr. Hiscock ben 2 Apr 2026
purchase Bioventix plc announced that Chief Executive Officer Peter Harrison and his wife Abigail Harrison purchased a total of 2,130 ordinary shares at 1,849 pence per share on April 8, 2026. Following these purchases, Peter Har 8 Apr 2026
purchase Bioventix plc announced that its Non-Executive Chairman, Ian Nicholson, purchased 1,000 ordinary shares at 1,848 pence per share on April 10, 2026. Following this transaction, Mr. Nicholson beneficially owns 14,500 ordin 13 Apr 2026
purchase Bioventix plc announced that Chief Financial Officer Bruce Hiscock purchased 66 ordinary shares at 1,679 pence per share on April 27, 2026, through a dividend reinvestment plan. Following this transaction, Mr. Hiscock be 28 Apr 2026
purchase Bioventix plc announced that its Chief Financial Officer, Bruce Hiscock, purchased 534 ordinary shares at 1,799 pence per share, totaling £9,600. Following this transaction, Mr. Hiscock now beneficially owns 2,200 ordina 24 Jun 2026
Company filings. Not investment advice.